⌘K
Anduril Investors
Deals on record
1
Common Fundraising Type
Series C
Rivermark Medical
Benign Prostatic Hyperplasia • Minimally invasive device
Rivermark Medical develops the FloStent™ System, a minimally invasive device for treating Benign Prostatic Hyperplasia (BPH) that aims to restore urinary function while preserving sexual function.